UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 135

Sortiert nach

Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients

Annals of oncology, 2018-01, Vol.29 (1), p.223-229

2018

Link zum Volltext

Verfügbarkeit prüfen

Minimally invasive genomic and transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomes

Annals of oncology, 2016-04, Vol.27 (4), p.635-641

2016

Link zum Volltext

Verfügbarkeit prüfen

High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients

Annals of oncology, 2017-04, Vol.28 (4), p.741-747

2017

Link zum Volltext

Verfügbarkeit prüfen

Cancer of unknown primary: progress in the search for improved and rapid diagnosis leading toward superior patient outcomes

Annals of oncology, 2012-02, Vol.23 (2), p.298-304

2012

Link zum Volltext

Verfügbarkeit prüfen

Carcinoid tumours: predicting the location of the primary neoplasm based on the sites of metastases

European radiology, 2013-02, Vol.23 (2), p.400-407

2013

Link zum Volltext

Verfügbarkeit prüfen

Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma

British journal of cancer, 2015-06, Vol.113 (1), p.64-68

2015

Link zum Volltext

Verfügbarkeit prüfen

A predictive model of inflammatory markers and patient-reported symptoms for cachexia in newly diagnosed pancreatic cancer patients

Supportive care in cancer, 2017-06, Vol.25 (6), p.1809-1817

2017

Link zum Volltext

Verfügbarkeit prüfen

The sequential radiographic effects of preoperative chemotherapy and (chemo)radiation on tumor anatomy in patients with localized pancreatic cancer

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2020-11, Vol.20, p.S18-S18

2020

Link zum Volltext

Verfügbarkeit prüfen

Carcinoma of unknown primary with gastrointestinal profile: immunohistochemistry and survival data for this favorable subset

International journal of clinical oncology, 2014-06, Vol.19 (3), p.479-484

2014

Link zum Volltext

Verfügbarkeit prüfen

A retrospective study of ampullary adenocarcinomas: overall survival and responsiveness to fluoropyrimidine-based chemotherapy

Annals of oncology, 2013-09, Vol.24 (9), p.2349-2353

2013

Link zum Volltext

Verfügbarkeit prüfen

High prevalence of mutantKRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients

Annals of oncology, 2017-04, Vol.28 (4), p.741-747

2017

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single‐center, open‐label, phase 2 study

Cancer, 2017-03, Vol.123 (6), p.1011-1017

2017

Link zum Volltext

Verfügbarkeit prüfen

Multi-institutional Phase II Trial of Induction Cetuximab Gemcitabine and Oxaliplatin, followed by Radiotherapy with Concurrent Capecitabine, and Cetuximab, for Locally Advanced Pancreatic Adenocarcinoma (LAPC)

International journal of radiation oncology, biology, physics, 2010, Vol.78 (3), p.S102-S102

2010

Link zum Volltext

Verfügbarkeit prüfen

Spontaneous pneumothorax in malignancy: A case report and review of the literature

Annals of oncology, 2000-07, Vol.11 (7), p.887-889

2000

Link zum Volltext

Verfügbarkeit prüfen

Metastatic patterns in adenocarcinoma

Cancer, 2006-04, Vol.106 (7), p.1624-1633

2006

Link zum Volltext

Verfügbarkeit prüfen

The integration of chemoradiation in the care of patient with localized pancreatic cancer

Cancer radiothérapie, 2009-04, Vol.13 (2), p.123-143

2009

Link zum Volltext

Verfügbarkeit prüfen

CT imaging features of acinar cell carcinoma and its hepatic metastases

Abdominal imaging, 2013-12, Vol.38 (6), p.1383

2013

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic strategies for unknown primary cancer

Cancer, 2004-05, Vol.100 (9), p.1776-1785

2004

Link zum Volltext

Verfügbarkeit prüfen

Low volume institutions are associated with delay and omission of adjuvant chemotherapy for resected pancreatic adenocarcinoma independent of surgical approach

HPB (Oxford, England), 2017-04, Vol.19, p.S60-S60

2017

Link zum Volltext

Verfügbarkeit prüfen

328 POSTER Phase II study of MTOR-inhibitor RAD001 and erlotinib for advanced, gemcitabine-refractory pancreatic cancer

European journal of cancer supplements, 2008, Vol.6 (12), p.104-104

2008

Link zum Volltext

Verfügbarkeit prüfen

Phase I trial of oral talactoferrin alfa in refractory solid tumors

Investigational new drugs, 2006-05, Vol.24 (3), p.233-240

2006

Link zum Volltext

Verfügbarkeit prüfen

Patients with carcinoma of unknown primary with isolated carcinomatosis on presentation: Clinicopathologic features and survival data

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.4123-4123

2011

Link zum Volltext

Verfügbarkeit prüfen

Carcinoma of unknown primary site (CUP): Outcomes in patients with a colorectal molecular profile treated with site-specific chemotherapy

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.3563-3563

2011

Link zum Volltext

Verfügbarkeit prüfen

Effect of a gene expression-based tissue of origin test's impact on patient management for difficult-to-diagnose primary cancers

Journal of clinical oncology, 2011-02, Vol.29 (4_suppl), p.459-459

2011

Link zum Volltext

Verfügbarkeit prüfen

Comparison of ampullary adenocarcinomas and duodenal adenocarcinomas with regard to clinical outcomes and responsiveness to fluoropyrimidine-based chemotherapy

Journal of clinical oncology, 2011-02, Vol.29 (4_suppl), p.204-204

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 135

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(129)
Mit Volltextzugriff
(124)

Publikationsform

Sprache

Englisch
(135)
Japanisch
(23)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients

Minimally invasive genomic and transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomes

High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients

Cancer of unknown primary: progress in the search for improved and rapid diagnosis leading toward superior patient outcomes

Carcinoid tumours: predicting the location of the primary neoplasm based on the sites of metastases

Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma

A predictive model of inflammatory markers and patient-reported symptoms for cachexia in newly diagnosed pancreatic cancer patients

The sequential radiographic effects of preoperative chemotherapy and (chemo)radiation on tumor anatomy in patients with localized pancreatic cancer

Carcinoma of unknown primary with gastrointestinal profile: immunohistochemistry and survival data for this favorable subset

A retrospective study of ampullary adenocarcinomas: overall survival and responsiveness to fluoropyrimidine-based chemotherapy

High prevalence of mutantKRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients

Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single‐center, open‐label, phase 2 study

Multi-institutional Phase II Trial of Induction Cetuximab Gemcitabine and Oxaliplatin, followed by Radiotherapy with Concurrent Capecitabine, and Cetuximab, for Locally Advanced Pancreatic Adenocarcinoma (LAPC)

Spontaneous pneumothorax in malignancy: A case report and review of the literature

Metastatic patterns in adenocarcinoma

The integration of chemoradiation in the care of patient with localized pancreatic cancer

CT imaging features of acinar cell carcinoma and its hepatic metastases

Diagnostic strategies for unknown primary cancer

Low volume institutions are associated with delay and omission of adjuvant chemotherapy for resected pancreatic adenocarcinoma independent of surgical approach

328 POSTER Phase II study of MTOR-inhibitor RAD001 and erlotinib for advanced, gemcitabine-refractory pancreatic cancer

Phase I trial of oral talactoferrin alfa in refractory solid tumors

Patients with carcinoma of unknown primary with isolated carcinomatosis on presentation: Clinicopathologic features and survival data

Carcinoma of unknown primary site (CUP): Outcomes in patients with a colorectal molecular profile treated with site-specific chemotherapy

Effect of a gene expression-based tissue of origin test's impact on patient management for difficult-to-diagnose primary cancers

Comparison of ampullary adenocarcinomas and duodenal adenocarcinomas with regard to clinical outcomes and responsiveness to fluoropyrimidine-based chemotherapy

Suchergebnisse filtern